Fair value, page-47

Exactly why simply waiting for some sort of efficacy data is a poor way to manage a company. It is a complete gamble, red or black on the roulette wheel.

What if all four measures show results but the viral load is only reduced by 70% with the highest does? That is a measure of efficacy but it is one that is unlikely to generate interest from a partner.

We all hope TT-034 works and works well. All that I am doing is pointing out the risks with the present situation.